Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tomatidine is a natural steroidal alkaloid found in green tomatoes and tomato leaves, where it serves as the aglycone of tomatine[4][3]. It has demonstrated multiple biological activities in preclinical studies. Tomatidine acts as a potent inhibitor of skeletal muscle atrophy by stimulating mTOR complex 1 (mTORC1) signaling, leading to increased protein synthesis, muscle hypertrophy, and improved strength and exercise capacity[2][5]. It also exhibits antibacterial activity against Staphylococcus aureus small-colony variants by targeting the bacterial ATP synthase subunit C[1][7]. Additional reported effects include anti-inflammatory action via inhibition of NF-κB signaling pathway and JNK signaling pathway, induction of autophagy, antiviral properties (e.g., against dengue virus), cardio- and neuroprotective effects, cholesterol-lowering activity in animal models, and potential benefits for osteoporosis and longevity research[4][6][7]. Tomatidine is not currently approved as a pharmaceutical drug but is under investigation as a lead compound for several indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tomatidine.